Patents by Inventor Ilona Domracheva

Ilona Domracheva has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10561681
    Abstract: The present invention relates to a novel cancer metastasis preventing and curing selenopheno[h]chromene derivatives, as well as methods of their manufacturing and use in different pharmaceutical compositions for the treatment and/or prevention of primary cancer and its metastasis by administration of such substances.
    Type: Grant
    Filed: July 21, 2016
    Date of Patent: February 18, 2020
    Assignee: Latvian Institute of Organic Synthesis
    Inventors: Pavels Arsenjans, Jelena Vasiljeva, Ilona Domracheva, Irina Shestakova, Ivars Kalvins
  • Publication number: 20190298758
    Abstract: The present invention relates to a novel cancer metastasis preventing and curing selenopheno[h]chromene derivatives, as well as methods of their manufacturing and use in different pharmaceutical compositions for the treatment and/or prevention of primary cancer and its metastasis by administration of such substances.
    Type: Application
    Filed: July 21, 2016
    Publication date: October 3, 2019
    Inventors: Pavels Arsenjans, Jelena Vasiljeva, Ilona Domracheva, Irina Shestakova, Ivars Kalvins
  • Patent number: 9908893
    Abstract: The thieno[2,3-b]pyridines of general formula (I), wherein R1 is Me, C6H5, 3,4,5-(OMe)3C6H2, NH2; R2 is H, CN, COMe, COOC1-4alkyl, COOC2H4OMe, COOC2H4OPr(n); R3 is C6H4R6, 3,4-OCH2O—C6H3; 2-furanyl; R6 is 4-Cl, 4-NO2, 4-N(C1-4alkyl)2, 3-(C1-4alkyloxy), 4-(C1-4alkyloxy), 3,4-(C1-4alkyloxy)2, 3,4,5-(C1-4alkyloxy)3; R4 is NH2, NHCOMe; R5 is CN, COMe, COC6H4R7; CO-(2-naphthyl); R7 is H, 4-F, 4-Cl, 3-OMe, 4-OMe, 2,4-(OMe)2, 3,4,5-(OMe)3 as multidrug resistance modulators to increase the effectiveness of chemotherapy in cancer treatment.
    Type: Grant
    Filed: June 11, 2013
    Date of Patent: March 6, 2018
    Assignee: LATVIAN INSTITUTE OF ORGANIC SYNTHESIS
    Inventors: Ivars Kalvins, Aivars Krauze, Signe Grinberga, Laura Krasnova, Elina Jaschenko, Ilona Domracheva, Ilze Adlere, Zigmars Andzans, Irina Shestakova, Gunars Duburs
  • Publication number: 20160137664
    Abstract: The thieno[2,3-b]pyridines of general formula (I), wherein R1 is Me, C6H5, 3,4,5-(OMe)3C6H2, NH2; R2 is H, CN, COMe, COOC1-4alkyl, COOC2H4OMe, COOC2H4OPr(n); R3 is C6H4R6, 3,4-OCH2O—C6H3; 2-furanyl; R6 is 4-Cl, 4-NO2, 4-N(C1-4alkyl)2, 3-(C1-4alkyloxy), 4-(C1-4alkyloxy), 3,4-(C1-4alkyloxy)2, 3,4,5-(C1-4alkyloxy)3; R4 is NH2, NHCOMe; R5 is CN, COMe, COC6H4R7; CO-(2-naphthyl); R7 is H, 4-F, 4-Cl, 3-OMe, 4-OMe, 2,4-(OMe)2, 3,4,5-(OMe)3 as multidrug resistance modulators to increase the effectiveness of chemotherapy in cancer treatment.
    Type: Application
    Filed: June 11, 2013
    Publication date: May 19, 2016
    Inventors: Ivars KALVINS, Aivars KRAUZE, Signe GRINBERGA, Laura KRASNOVA, Elina JASCHENKO, Ilona DOMRACHEVA, Ilze ADLERE, Zigmars ANDZANS, Irina SHESTAKOVA, Gunars DUBURS
  • Patent number: 7078418
    Abstract: Described are new 1-aziridino-1-hydroxyiminomethyl derivatives with the general formula (I), wherein R is able to is a single bond or a linker moiety capable of covalently bonding two aziridine oxime groups, R1 and R2 independently of one another are selected from the group consisting of —H, —CH3, —C2H5, —CN, —COOH, —COOCH3, —COOC2H5, —CONH2, or —C6H5 group, and n is the whole number 2, provided that R1 and R2 are not both —H and provided that R1 is not —H if R2 is —CH3 and R1 is not —CH3 if R2 is —H The compounds of general formula (I) show antitumor activity.
    Type: Grant
    Filed: September 22, 2000
    Date of Patent: July 18, 2006
    Inventors: Ivars Kalvins, Viktor Adrianov, Irina Shestakova, Iveta Kanepe, Ilona Domracheva